EFG
Ethos Financial Group’s UroGen Pharma URGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-10,500
| Closed | -$112K | – | 527 |
|
2025
Q1 | $112K | Hold |
10,500
| – | – | 0.01% | 424 |
|
2024
Q4 | $112K | Hold |
10,500
| – | – | 0.01% | 327 |
|
2024
Q3 | $133K | Hold |
10,500
| – | – | 0.02% | 285 |
|
2024
Q2 | $176K | Hold |
10,500
| – | – | 0.03% | 267 |
|
2024
Q1 | $158K | Hold |
10,500
| – | – | 0.03% | 265 |
|
2023
Q4 | $158K | Hold |
10,500
| – | – | 0.03% | 262 |
|
2023
Q3 | $147K | Hold |
10,500
| – | – | 0.04% | 172 |
|
2023
Q2 | $97K | Hold |
10,500
| – | – | 0.03% | 145 |
|
2023
Q1 | $97K | Hold |
10,500
| – | – | 0.03% | 182 |
|
2022
Q4 | $93.1K | Buy |
+10,500
| New | +$93.1K | 0.03% | 142 |
|